Global /India /Healthcare /Drug Manufacturers - General /GUJTHEM

Gujarat Themis Biosyn Ltd.

GUJTHEM

• NSE: GUJTHEM • Delayed

363.58INR -3.2%

3.80 USD

As of 5 June 2026, Gujarat Themis Biosyn Ltd. has a market cap of $427.55M USD, ranking #16232 globally and #868 in India. It ranks #1466 in the Healthcare sector, and #532 in the Drug Manufacturers - General industry.

Global Rank

16232

Country Rank

868

Sector Rank

1466

Industry Rank

532

Key Stats

Market Cap

$427.55MUSD

40.95B INR

Enterprise Value

$434.13MUSD

41.57B INR

Revenue (TTM)

$16.63MUSD

1.59B INR

EBITDA (TTM)

$7.14MUSD

684.01M INR

Net Income (TTM)

$4.99MUSD

477.89M INR

EBITDA Margin

43%

Profit Margin

30%

PE Ratio

85.7

PS Ratio

25.7

PB Ratio

15.5

EV/EBITDA

59.4

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Sachin Patel open_in_new

Employees

221

Founded

1981

Website

gtbl.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.2%	14%	49%	21%	-18%	-15%	33%	53%	53%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	GUJTHEM Gujarat Themis Biosyn Ltd ISIN: INE942C01045 Shares Out.: Shares Outstanding: 108.965M¹ Shares Float: 30.813M² TV: TradingView: NSE: GUJTHEM SA: Stock Analysis: NSE: GUJTHEM YF: Yahoo Finance: GUJTHEM.NS GF: Google Finance: NSE: GUJTHEM BA: Barron's: GUJTHEM MS: Morningstar: XNSE: GUJTHEM	363.58 INR	TV: TradingView: NSE: GUJTHEM SA: Stock Analysis: NSE: GUJTHEM YF: Yahoo Finance: GUJTHEM.NS GF: Google Finance: NSE: GUJTHEM BA: Barron's: GUJTHEM MS: Morningstar: XNSE: GUJTHEM
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	506879 (GUJTHEM) Gujarat Themis Biosyn Ltd ISIN: INE942C01045 TV: TradingView: BSE: GUJTHEM SA: Stock Analysis: BOM: 506879 YF: Yahoo Finance: 506879.BO GF: Google Finance: BOM: 506879 BA: Barron's: 506879 MS: Morningstar: XBOM: 506879	375.85 INR	TV: TradingView: BSE: GUJTHEM SA: Stock Analysis: BOM: 506879 YF: Yahoo Finance: 506879.BO GF: Google Finance: BOM: 506879 BA: Barron's: 506879 MS: Morningstar: XBOM: 506879

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.55B 4.27T INR 10K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.11B 1.73T INR 4K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$14.95B 1.43T INR 3K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.56B 1.11T INR 3K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.73B 931.67B INR 2K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.57B 916.53B INR 2K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 178K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 128K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 84K%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 76K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 68K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 65K%	20.5	Switzerland

chevron_leftBack